Depression News and Research

Latest Depression News and Research

IMS develops review on weight gain at the menopause

To mark World Menopause Day (18th October) the International Menopause Society has developed a state-of-the-science review on weight gain at the menopause. This report is published in the peer-reviewed journal, Climacteric.

16 Oct 2012

LRRK2 inhibitors may provide neuroprotection for patients with Parkinson's

For decades, patients with Parkinson's disease (PD) have had the same experience. Their hands start to shake uncontrollably, their limbs become rigid and they lose their balance. Years before those movement problems set in, many begin struggling with fainting, incontinence, sexual dysfunction, anxiety and depression. Many patients are still treated with a 42-year-old drug called L-DOPA, which temporarily staves off symptoms but can itself cause heart arrhythmias, stomach bleeding and hallucinations.

16 Oct 2012

Transcranial magnetic stimulation can benefit patients with depression, debilitating tinnitus

Three patients who have suffered periodic major depression throughout their adult lives told an audience attending a Loyola Grand Rounds presentation how their lives have been transformed by a new magnetic therapy.

16 Oct 2012

U-M professor receives 2012 ASA Excellence in Research Award

The American Society of Anesthesiologists (ASA) today presented Ralph Lydic, Ph.D. with its 2012 ASA Excellence in Research Award. Dr. Lydic, well known for his research on the neurobiology of sleep and breathing, received the award at the ANESTHESIOLOGY 2012 annual meeting in Washington, D.C.

16 Oct 2012

Researchers discover why people exposed to war more likely to develop chronic diseases

Wayne State University School of Medicine researchers may have discovered why people exposed to war are at increased risk to develop chronic problems like heart disease years later. And the culprit that links the two is surprising.

16 Oct 2012

New findings on depression, decision-making and cognition in the teen brain

The brain's "reward system," those brain circuits and structures that mediate the experience and pursuit of pleasure, figured prominently in several studies.

16 Oct 2012

HIV agent offers HER2-positive breast cancer hope

A drug used to treat HIV infection may be a new treatment line for patients with an aggressive type of breast cancer, US researchers believe.

15 Oct 2012

Enrollment complete in Idera's IMO-3100 Phase 2 trial for psoriasis

Idera Pharmaceuticals today announced that it had completed patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 trial of IMO-3100 in patients with moderate-to-severe plaque psoriasis. IMO-3100 is an antagonist of specific Toll-like Receptors (TLRs) that the Company is developing for the treatment of psoriasis and other autoimmune diseases.

15 Oct 2012

New research on how the brain develops during transition period from childhood to adulthood

Scientists presented new research today on how the brain develops during the dynamic and vulnerable transition period from childhood to adulthood. The findings underscore the uniqueness of adolescence, revealing factors that may influence depression, decision-making, learning, and social relationships.

15 Oct 2012

Pregnancy stress can cut brain benefits of motherhood

A new study in animals shows that chronic stress during pregnancy prevents brain benefits of motherhood, a finding that researchers suggest could increase understanding of postpartum depression.

15 Oct 2012

Chromosome 3p21.1 locus contains common genetic risk for bipolar disorder

One of the biggest challenges in psychiatric genetics has been to replicate findings across large studies. Scientists at King's College London, Institute of Psychiatry have now performed one of the largest ever genetic replication studies of bipolar affective disorder, with 28,000 subjects recruited from 36 different research centers. Their findings provide compelling evidence that the chromosome 3p21.1 locus contains a common genetic risk for bipolar disorder, the PBRM1 gene.

15 Oct 2012

New insights into how brain responds to extreme stress

Researchers report new insights into how the brain responds to extreme stress, whether from combat, natural disasters, or repeated violent competition. The insights offer hope for detecting and treating several widespread and debilitating neuropsychiatric disorders, and were presented at Neuroscience 2012, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

15 Oct 2012

Highlights of Mount Sinai research at Neuroscience 2012

Researchers from Mount Sinai School of Medicine are presenting important discoveries on the involvement of the immune system and dopamine cells in the onset of depression at Neuroscience 2012, the Society for Neuroscience's 42nd annual meeting on October 13 -17 in New Orleans, and are available for interviews.

15 Oct 2012

BC Cancer Agency second prestigious Vancouver institution to install MILabs Molecular Imaging System

MILabs is pleased to announce that the BC Cancer Agency, located in Vancouver, British Columbia will install a MILabs U‐SPECT/CT system to expand their current molecular oncology imaging and research capabilities. The U‐SPECT/CT is able to deliver high resolution, sensitivity and scanning speed contributing to outstanding quantification results and the ability to detect heterogeneous molecular processes in tumors.

12 Oct 2012

AACR conference to focus on scientific and lifestyle strategies for cancer prevention

The American Association for Cancer Research will host the 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research at the Hilton Anaheim from Oct. 16-19, 2012.

12 Oct 2012

Factors linked to self-harm in schizophrenia identified

Polysubstance abuse and a high premorbid IQ are significantly associated with self-harm in patients with schizophrenia, UK researchers report.

11 Oct 2012

MDD with subthreshold hypomania ‘should be merged with bipolar II’

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

11 Oct 2012

Enrollment complete in Euthymics’ amitifadine phase 2b/3a trial for major depressive disorder

Euthymics Bioscience, Inc. today announced completion of enrollment in the advanced clinical study of its lead product candidate amitifadine (formerly called EB-1010), a novel serotonin-preferring triple reuptake inhibitor for the treatment of major depressive disorder (MDD).

11 Oct 2012

Grand Challenges Canada funds 15 new projects to improve mental health diagnosis and care

Grand Challenges Canada, which is funded by the Government of Canada, today announced a landmark $19.4 million in support of 15 innovative, pioneering projects designed to improve mental health diagnosis and care in developing countries, many of them nations ravaged by conflict and disaster as well as poverty.

11 Oct 2012

WHO calls for end to stigma on World Mental Health Day

"Wednesday (October 10th) is World Mental Health Day," VOA News reports, noting, "The World Health Organization is using the occasion to call for an end to stigma against those who suffer from depression and other mental disorders."

11 Oct 2012